Leblanc; Melissa
Patent Applications and Registrations
Patent applications and USPTO patent grants for Leblanc; Melissa.The latest application filed is for "inhibitors of cyclin-dependent kinase 7 (cdk7)".
- Leblanc; Melissa - Laval CA
- LEBLANC; Melissa - US
| Patent | Date |
|---|---|
| Heteroaromatic compounds useful for the treatment of proliferative diseases Grant 11,040,957 - Ciblat , et al. June 22, 2 | 2021-06-22 |
| Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20210061803 - Ciblat; Stephane ; et al. | 2021-03-04 |
| Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7) Grant 10,906,889 - Gray , et al. February 2, 2 | 2021-02-02 |
| Inhibitors of cyclin-dependent kinase 7 (CDK7) Grant 10,865,206 - Ciblat , et al. December 15, 2 | 2020-12-15 |
| Inhibitors of cyclin-dependent kinase 7 (CDK7) Grant 10,519,135 - Sprott , et al. Dec | 2019-12-31 |
| Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20190337940 - Ciblat; Stephane ; et al. | 2019-11-07 |
| Heteroaromatic Compounds Useful For The Treatment Of Proliferative Diseases App 20190292167 - Ciblat; Stephane ; et al. | 2019-09-26 |
| Heteroaromatic Compounds Useful For The Treatment Of Proliferative Diseases App 20190241541 - Ciblat; Stephane ; et al. | 2019-08-08 |
| Inhibitors of cyclin-dependent kinase 7 (CDK7) Grant 10,308,648 - Ciblat , et al. | 2019-06-04 |
| Polycyclic Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20190031642 - Gray; Nathanael ; et al. | 2019-01-31 |
| Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20180319772 - Sprott; Kevin ; et al. | 2018-11-08 |
| Inhibitors of cyclin-dependent kinase 7 (CDK7) Grant 10,106,526 - Sprott , et al. October 23, 2 | 2018-10-23 |
| Inhibitors of cyclin-dependent kinase 7 (CDK7) Grant 10,059,690 - Ciblat , et al. August 28, 2 | 2018-08-28 |
| Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7) Grant 10,047,070 - Gray , et al. August 14, 2 | 2018-08-14 |
| Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20180208578 - Ciblat; Stephane ; et al. | 2018-07-26 |
| Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20170327496 - Ciblat; Stephane ; et al. | 2017-11-16 |
| Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20170183355 - Sprott; Kevin ; et al. | 2017-06-29 |
| Inhibitors of cytomegalovirus Grant 9,505,775 - Thibeault , et al. November 29, 2 | 2016-11-29 |
| Heteromaromatic Compounds Useful For The Treatment Of Prolferative Diseases App 20160264552 - Ciblat; Stephane ; et al. | 2016-09-15 |
| Polycyclic Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20160264554 - Gray; Nathanael ; et al. | 2016-09-15 |
| Heteroaromatic Compounds Useful For The Treatment Of Prolferative Diseases App 20160264551 - Ciblat; Stephane ; et al. | 2016-09-15 |
| Cytomegalovirus inhibitor compounds Grant 9,249,158 - Fader , et al. February 2, 2 | 2016-02-02 |
| Inhibitors Of Cytomegalovirus App 20150274744 - Thibeault; Carl ; et al. | 2015-10-01 |
| Cytomegalovirus Inhibitor Compounds App 20150080366 - Fader; Lee ; et al. | 2015-03-19 |
| Hepatitis C Inhibitor Compounds App 20120077737 - Llinas-Brunet; Montse ; et al. | 2012-03-29 |
| Hepatitis C Inhibitor Compounds App 20110294778 - LLINAS-BRUNET; Montse ; et al. | 2011-12-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 